Literature DB >> 18502466

Studies on naturally occurring infectious bursal disease viruses suggest that a single amino acid substitution at position 253 in VP2 increases pathogenicity.

D J Jackwood1, B Sreedevi, L J LeFever, S E Sommer-Wagner.   

Abstract

Three classic IBDV strains were previously isolated from commercial layer chicken flocks and shown to be phylogenetically related to vaccine strains but pathogenic in susceptible chickens. In this study, their viral genomes were sequenced and compared to sequences of vaccines being used in those flocks. The vaccine strains examined were sequenced directly from the manufacturer and had identical genome segment B sequences. Compared to these vaccines, the GA-1, H-30 and CS-2-35 isolates each had one silent mutation in the gene that encodes VP1. Compared to the two vaccines used at the time CS-2-35 was isolated, the segment A sequence of CS-2-35 contained numerous nucleotide and amino acid mutations suggesting the CS-2-35 virus was not closely related to these vaccines. This virus however did have amino acid mutations in VP2 that are reported to be necessary for replication in cell culture and lacked two of the three amino acid mutations previously shown to be necessary for virulence. These data suggest that CS-2-35 was a descendant from an attenuated strain of IBDV. When the segment A genomic sequences of the GA-1 and H-30 viruses were compared to the vaccines being used in those flocks they were most closely related to the attenuated D78 vaccine strain. In genome segment A, three nucleotide mutations in GA-1 and four in H-30 were observed compared to the D78 classic vaccine. These nucleotide mutations caused one amino acid (H253N) change in the GA-1 virus and two amino acids (H253Q and G259D) were different in the H-30 virus. In addition, both the GA-1 and H-30 viruses had the amino acid G76 in VP2 that appears to be unique to the vaccine D78. The data suggest that GA-1 and H-30 are genetically related and have a common ancestor even though they were isolated from geographically distant flocks. The evidence also suggests that GA-1, H-30 and CS-2-35 could be reversions from attenuated vaccine viruses or by coincidence genetically resemble classic IBDV vaccines. It should be noted that some of the classic virus vaccines were not being used according to the manufacturer's recommendations at the time the GA-1, H-30 and CS-2-35 strains were isolated. Together, the molecular and pathogenicity data indicate that a single amino acid mutation from Histidine (H) to Glutamine (Q) or Asparagine (N) at position 253 in VP2 will markedly increase the virulence of an attenuated IBDV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502466     DOI: 10.1016/j.virol.2008.04.018

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

1.  Identification and molecular analysis of infectious bursal disease in broiler farms in the Kurdistan Regional Government of Iraq.

Authors:  Oumed Gerjis M Amin; Daral J Jackwood
Journal:  Trop Anim Health Prod       Date:  2014-07-16       Impact factor: 1.559

2.  Identification and genetic analysis of infectious bursal disease viruses from field outbreaks in Kerala, India.

Authors:  D Nandhakumar; R Rajasekhar; G Logeshwaran; Chintu Ravishankar; Stephy Rose Sebastian; R Anoopraj; K Sumod; Binu K Mani; G Chaithra; Chandankar Vaidehi Deorao; Koshy John
Journal:  Trop Anim Health Prod       Date:  2019-11-08       Impact factor: 1.559

3.  Sequence variability and evolution of the terminal overlapping VP5 gene of the infectious bursal disease virus.

Authors:  Martín Hernández; Pedro Villegas; Diego Hernández; Alejandro Banda; Leticia Maya; Valeria Romero; Gonzalo Tomás; Ruben Pérez
Journal:  Virus Genes       Date:  2010-05-01       Impact factor: 2.332

4.  Further evidence for very virulent infectious bursal disease virus in vaccinated chickens in Nigeria.

Authors:  Olajide Adewale Owolodun; Bitrus Yakubu; Anvou Rachael Jambol; Benshak John Audu; Bajehson Banenat Dogonyaro; Pam Dachung Luka
Journal:  Trop Anim Health Prod       Date:  2015-07-07       Impact factor: 1.559

5.  Molecular phylodynamics of infectious bursal disease viruses.

Authors:  Aditya A Agnihotri; Sudhakar P Awandkar; Mahesh B Kulkarni; Sambhaji G Chavhan; Ram C Kulkarni; Vishranti G Chavan
Journal:  Virus Genes       Date:  2022-04-18       Impact factor: 2.332

6.  Molecular characterization of Infectious Bursal Disease Virus isolated in Chile reveals several mutations in VP2 coding region and a reassortment in its genome.

Authors:  Miguel Guzmán; Leandro Cádiz; Alejandra Guerrero-Moncayo; Francisca Cáceres; Sonia Vidal; Lisette Lapierre; Leonardo Sáenz; Héctor Hidalgo
Journal:  Vet Res Commun       Date:  2022-08-03       Impact factor: 2.816

7.  Competitive replication of different genotypes of infectious bursal disease virus on chicken embryo fibroblasts.

Authors:  Lixue Shi; Haibin Li; Guangpeng Ma; Jiyong Zhou; Lianlian Hong; Xiaojuan Zheng; Yongping Wu; Yongzhi Wang; Yan Yan
Journal:  Virus Genes       Date:  2008-12-23       Impact factor: 2.332

8.  Genogrouping of Infectious Bursal Disease Viruses Circulating in Ethiopian Chickens: Proposal for Assigning Very Virulent Strains in the Country into New Sub Genogroup 3d.

Authors:  Fufa Dawo Bari
Journal:  Vet Med (Auckl)       Date:  2021-02-26

9.  Molecular characterization of two Bangladeshi infectious bursal disease virus isolates using the hypervariable sequence of VP2 as a genetic marker.

Authors:  Md Taohidul Islam; Thanh Hoa Le; Md Mostafizur Rahman; Md Alimul Islam
Journal:  J Vet Sci       Date:  2012-12       Impact factor: 1.672

10.  Avibirnavirus VP4 Protein Is a Phosphoprotein and Partially Contributes to the Cleavage of Intermediate Precursor VP4-VP3 Polyprotein.

Authors:  Sanying Wang; Boli Hu; Weiying Si; Lu Jia; Xiaojuan Zheng; Jiyong Zhou
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.